DA - CIMA - Oncología - Inmunoterapia - Artículos de Revista : [51]

Listar
Suscribirse para recibir un correo electrónico cada vez que se introduzca un ítem en esta colección. RSS Feed RSS Feed RSS Feed
Ítems de la colección (Ordenados por Fecha de envío en Descendente orden): 1 - 20 de 51
Fecha publicaciónTítuloTipoAutor(es)
2015Molecular and cellular basis for immunomodulation with monoclonal antibodiesArticuloMelero, I. (Ignacio)
2008TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer PatientsArticuloHonorato, B. (Beatriz); Alcalde, J. (Juan); Martinez-Monge, R. (Rafael), et al
2006Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapyArticuloZarate, R. (Ruth); Arias, F. (F.); Bandres, E. (Eva), et al
2001Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytesArticuloSarobe, P. (Pablo); Huarte, E. (Eduardo); Lasarte, J.J. (Juan José), et al
1999T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptidesArticuloLopez-Diaz-de-Cerio, A. (Ascensión); Casares, N. (Noelia); Lasarte, J.J. (Juan José), et al
1999Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxideArticuloLasarte, J.J. (Juan José); Corrales, F.J. (Fernando José); Casares, N. (Noelia), et al
2002Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteinsArticuloSarobe, P. (Pablo); Lasarte, J.J. (Juan José); Casares, N. (Noelia), et al
2002Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virusArticuloArribillaga, L. (Laura); Lopez-Diaz-de-Cerio, A. (Ascensión); Sarobe, P. (Pablo), et al
2003A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damageArticuloLasarte, J.J. (Juan José); Sarobe, P. (Pablo); Boya, P. (Patricia), et al
2003Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responsesArticuloLopez-Diaz-de-Cerio, A. (Ascensión); Lasarte, J.J. (Juan José); Casares, N. (Noelia), et al
2001Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunityArticuloCasares, N. (Noelia); Lasarte, J.J. (Juan José); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2003CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationArticuloCasares, N. (Noelia); Arribillaga, L. (Laura); Sarobe, P. (Pablo), et al
2000In situ localization of anion exchanger-2 in the human kidneyArticuloCastillo, J. (José E.); Martinez-Anso, E. (Eduardo); Malumbres, R. (Raquel), et al
2007The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experienceArticuloRodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2007Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study GroupArticuloRodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2007The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphomaArticuloRodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2007Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experienceArticuloRodriguez, J. (José); Conde, E. (Eulogio); Gutierrez, A. (Antonio), et al
2004Indolent lymphoma: the pathologist's viewpointArticuloPileri, S.A. (S.A.); Zinzani, P.L. (P.L.); Went, P. (P.), et al
2003Feasibility of idiotype vaccination in relapsed B-cell malignanciesArticuloInoges, S. (Susana); Rodriguez-Calvillo, M. (Mercedes); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2004Active immunotherapy in the treatment of haematological neoplasiasArticuloInoges, S. (Susana); Rodriguez-Calvillo, M. (Mercedes); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
Ítems de la colección (Ordenados por Fecha de envío en Descendente orden): 1 - 20 de 51